에이비엘바이오
44,700KRWMarket close of 10/20 (Tue)
Down -4.18%-1,950KRWMarket close of 10/20 (Tue)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)46,750KRWUp +4.59%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 45,650
- High
- 46,400
- Low
- 43,700
- Day range
- Day range low 43,700 high 46,400, open 45,650, close 44,700, previous close 46,650
- Volume
- 21×10K shares
- 9.5B KRW 0.43× the 20-session average
Market close of 10/20 (Tue)
Where it sits in the 1-year range
2%1-year close range 40,550 to 245,500 won, 2% up from the low
2% of the way up from the lowest close in 1 year (252 sessions) · -81.8% from the high
Something to check
1 to check: operating loss
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsto check-86.1B KRWOperating income over the last four quarters -86.1B KRW (loss)
- Daily moveusual range-4.18%-4.18%, 1.0× the usual (20-session average ±4.28%)That day -4.18% · usual ±4.28% · large-move threshold ±8.6%
- Trading valueusual range0.4×9.5B KRW, 0.4× the 20-session average0.43× the 20-session average · check threshold 3×
The other 3 are within the usual range
- Recent filings0Last 14 days
- Foreign & institutional+7.1B KRWusual range
- Data date10/20 (Tue)Market close
See the full check report
Same sector · 제약
Down -1.68%· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 셀트리온 | Close over the last 20 sessions +11.4% | Down -0.40% | 139.2B KRW |
| 삼성바이오로직스 | Close over the last 20 sessions -1.3% | Down -2.52% | 129.9B KRW |
| 삼익제약 | Close over the last 20 sessions -20.4% | Up +2.77% | 76.0B KRW |
| 녹십자엠에스 | Close over the last 20 sessions +30.5% | Up +6.67% | 55.6B KRW |
| 유한양행 | Close over the last 20 sessions +11.5% | Down -1.37% | 41.6B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 25 days
- Next data 10/22 (Thu) after 08:50
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.